Sawako Kuruma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sawako Kuruma has a total of 112 co-authors. Here are the top co-authors by number of shared publications:
- Terumi Kamisawa
Department of Internal Medicine, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
23 shared publications Taku Tabata
Department of Hematology, Tokyo Metropolitan Komagome Hospital
18 shared publicationsTakashi Fujiwara
Department of Gastroenterology, Tokyo Metropolitan Komagome Hospital
14 shared publicationsGo Kuwata
Department of Gastroenterology, Tokyo Metropolitan Komagome Hospital
13 shared publicationsJunko Fujiwara
Department of Hematology, Tokyo Metropolitan Komagome Hospital
13 shared publications- Kazuro Chiba
Department of Gastroenterology, Tokyo Metropolitan Komagome Hospital
13 shared publications
Latest Publications
- 25 November 2019
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 13 (3) , 443-447
Carcinoma in situ of the pancreas with pancreatic duct stricture persistent for 4 years diagnosed by serial pancreatic juice aspiration cytologic examination (SPACE)
Serial pancreatic juice aspiration cytologic examination (SPACE) by nasopancreatic tube placement can give us an opportunity to diagnose early-stage pancreatic cancer with higher sensitivity and specificity compared with conventional pancreatic cytology by one-time pancreatic juice aspiration or pancreatic duct brushing. We performed SPACE in a patient with persistent pancreatic duct stricture (PDS) with gradually advancing pancreatic parenchyma atrophy (PPA) in the pancreas tail. The result of SPACE was suggestive of pancreatic carcinoma, and distal pancreatectomy was performed. Histopathological examination of the resected specimen revealed carcinoma in situ of the pancreas. The present case could indicate that any PDS becomes a candidate for SPACE especially in a patient with PPA, although the PDS remains unchanged for a long period.
- 25 November 2019
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 13 (3) , 443-447
Carcinoma in situ of the pancreas with pancreatic duct stricture persistent for 4 years diagnosed by serial pancreatic juice aspiration cytologic examination (SPACE)
Serial pancreatic juice aspiration cytologic examination (SPACE) by nasopancreatic tube placement can give us an opportunity to diagnose early-stage pancreatic cancer with higher sensitivity and specificity compared with conventional pancreatic cytology by one-time pancreatic juice aspiration or pancreatic duct brushing. We performed SPACE in a patient with persistent pancreatic duct stricture (PDS) with gradually advancing pancreatic parenchyma atrophy (PPA) in the pancreas tail. The result of SPACE was suggestive of pancreatic carcinoma, and distal pancreatectomy was performed. Histopathological examination of the resected specimen revealed carcinoma in situ of the pancreas. The present case could indicate that any PDS becomes a candidate for SPACE especially in a patient with PPA, although the PDS remains unchanged for a long period.
- 17 April 2019
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 12 (5) , 473-478
Hyper-dense fluid on plain computed tomography may reveal a ruptured aneurysm in patients with median arcuate ligament syndrome
Rupture of abdominal aneurysms associated with median arcuate ligament syndrome (MALS) is a serious condition and requires accurate diagnosis in a clinical setting. We examined three patients with this condition: two women aged 45 and 71 years, and a 61-year-old man. They complained of abdominal pain and had fluid collection around the duodenum. Plain computed tomography (CT) of the fluid collection revealed hyper density, which suggests the presence of blood. Moreover, contrast-enhanced CT revealed aneurysms in the pancreatic head area. Angiography revealed aneurysms of the branches of the gastroepiploic artery, which were treated by endovascular embolization in all patients. Thus, patients with abdominal pain and high-density fluid collection around the duodenum on plain CT may suffer from hemorrhage following rupture of MALS-associated aneurysms.
- 17 April 2019
- Published by Springer Nature in Clinical Journal of Gastroenterology
- Vol. 12 (5) , 473-478
Hyper-dense fluid on plain computed tomography may reveal a ruptured aneurysm in patients with median arcuate ligament syndrome
Rupture of abdominal aneurysms associated with median arcuate ligament syndrome (MALS) is a serious condition and requires accurate diagnosis in a clinical setting. We examined three patients with this condition: two women aged 45 and 71 years, and a 61-year-old man. They complained of abdominal pain and had fluid collection around the duodenum. Plain computed tomography (CT) of the fluid collection revealed hyper density, which suggests the presence of blood. Moreover, contrast-enhanced CT revealed aneurysms in the pancreatic head area. Angiography revealed aneurysms of the branches of the gastroepiploic artery, which were treated by endovascular embolization in all patients. Thus, patients with abdominal pain and high-density fluid collection around the duodenum on plain CT may suffer from hemorrhage following rupture of MALS-associated aneurysms.
- Open Access
- 23 January 2019
- Published by MDPI AG in Diagnostics
- Vol. 9 (1) , 15
Proposal for Endoscopic Ultrasonography Classification for Small Pancreatic Cancer
Backgrounds: Endoscopic ultrasonography (EUS) is used to observe the stricture of the main pancreatic duct (MPD) and in diagnosing pancreatic cancer (PC). We investigate the findings on EUS by referring to the histopathological findings of resected specimens. Materials and Methods: Six patients with carcinoma in situ (CIS) and 30 patients with invasive carcinoma of 20 mm or less were included. The preoperative EUS findings were classified as follows. A1: Simple stricture type—no findings around the stricture; A2: Hypoecho stricture type—localized hypoechoic area without demarcation around the stricture; A3: Tumor stricture type—tumor on the stricture; B: Dilation type—the dilation of the pancreatic duct without a downstream stricture; C: Parenchymal tumor type—tumor located apart from the MPD. Results: Classes A1 and A2 consisted of 2 CISs, and 4 invasive carcinomas included two cases smaller than 5 mm in diameter. Most of the cancers classified as A3 or C were of invasive carcinoma larger than 5 mm in diameter. All cancers classified as B involved CIS. Serial pancreatic-juice aspiration cytologic examination (SPACE) was selected for all types of cases, with a sensitivity of 92.0%, while EUS-guided fine needle aspiration cytology (EUS-FNA) was only useful for invasive carcinoma, and its sensitivity was 66.7%. Conclusions: Stricture without a tumor could be a finding for invasive PC and pancreatic duct dilation without a downstream stricture could be a finding indicative of CIS. Carcinoma smaller than 5 mm in diameter could not be recognized by EUS. SPACE had a high sensitivity for diagnosing small PC.
- 23 January 2019
- Published by MDPI AG in Diagnostics
- Vol. 9 (1) , 15
Open AccessProposal for Endoscopic Ultrasonography Classification for Small Pancreatic Cancer
Backgrounds: Endoscopic ultrasonography (EUS) is used to observe the stricture of the main pancreatic duct (MPD) and in diagnosing pancreatic cancer (PC). We investigate the findings on EUS by referring to the histopathological findings of resected specimens. Materials and Methods: Six patients with carcinoma in situ (CIS) and 30 patients with invasive carcinoma of 20 mm or less were included. The preoperative EUS findings were classified as follows. A1: Simple stricture type—no findings around the stricture; A2: Hypoecho stricture type—localized hypoechoic area without demarcation around the stricture; A3: Tumor stricture type—tumor on the stricture; B: Dilation type—the dilation of the pancreatic duct without a downstream stricture; C: Parenchymal tumor type—tumor located apart from the MPD. Results: Classes A1 and A2 consisted of 2 CISs, and 4 invasive carcinomas included two cases smaller than 5 mm in diameter. Most of the cancers classified as A3 or C were of invasive carcinoma larger than 5 mm in diameter. All cancers classified as B involved CIS. Serial pancreatic-juice aspiration cytologic examination (SPACE) was selected for all types of cases, with a sensitivity of 92.0%, while EUS-guided fine needle aspiration cytology (EUS-FNA) was only useful for invasive carcinoma, and its sensitivity was 66.7%. Conclusions: Stricture without a tumor could be a finding for invasive PC and pancreatic duct dilation without a downstream stricture could be a finding indicative of CIS. Carcinoma smaller than 5 mm in diameter could not be recognized by EUS. SPACE had a high sensitivity for diagnosing small PC.
- 1 August 2018
- Published by Springer Nature
- p. 99-104
Other Organ Involvements
- 15 June 2018
- Published by Japan Gastrointestinal Endoscopy Society in Progress of Digestive Endoscopy
- Vol. 92 (1) , 116-117
A case of adult T-cell leukemia (ATL) in which duodenal lesions appeared during treatment
A 62-year-old man who had been diagnosed with adult T-cell leukemia (ATL) and received chemotherapy and peripheral blood stem cell transplantation, had a loss of appetite and vomiting on the 89th day after transplantation. Upper and lower endoscopic examinations were performed. Reflecting the dense lymphocyte infiltration along the villous structure, it was observed as multiple white granular elevations on upper endoscopic examination. It was suggested that gastrointestinal lesions including those in the duodenum are a single disease as a systemic lesion, which may indicate a reduction in immunological ability and the disease state. If gastrointestinal symptoms appear during ATL therapy, the gastrointestinal tract should be searched to exclude cytomegalovirus infection and graft-versus-host disease, and the presence of multiple duodenal elevations may indicate ATL infiltration.
- 15 June 2018
- Published by Japan Gastrointestinal Endoscopy Society in Progress of Digestive Endoscopy
- Vol. 92 (1) , 116-117
A case of adult T-cell leukemia (ATL) in which duodenal lesions appeared during treatment
A 62-year-old man who had been diagnosed with adult T-cell leukemia (ATL) and received chemotherapy and peripheral blood stem cell transplantation, had a loss of appetite and vomiting on the 89th day after transplantation. Upper and lower endoscopic examinations were performed. Reflecting the dense lymphocyte infiltration along the villous structure, it was observed as multiple white granular elevations on upper endoscopic examination. It was suggested that gastrointestinal lesions including those in the duodenum are a single disease as a systemic lesion, which may indicate a reduction in immunological ability and the disease state. If gastrointestinal symptoms appear during ATL therapy, the gastrointestinal tract should be searched to exclude cytomegalovirus infection and graft-versus-host disease, and the presence of multiple duodenal elevations may indicate ATL infiltration.
- Open Access
Early Diagnosis to Improve the Poor Prognosis of Pancreatic Cancer
Pancreatic cancer (PC) has a poor prognosis due to delayed diagnosis. Early diagnosis is the most important factor for improving prognosis. For early diagnosis of PC, patients with clinical manifestations suggestive of PC and high risk for developing PC need to be selected for examinations for PC. Signs suggestive of PC (e.g., symptoms, diabetes mellitus, acute pancreatitis, or abnormal results of blood examinations) should not be missed, and the details of risks for PC (e.g., familial history of PC, intraductal mucin producing neoplasm, chronic pancreatitis, hereditary pancreatitis, or life habit) should be understood. Multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) can be performed for diagnosing PC, but the diagnostic ability of these examinations for PC is limited. Endoscopic diagnostic procedures, such as endoscopic ultrasonography, including fine-needle aspiration, and endoscopic retrograde pancreatocholangiography, including Serial Pancreatic-juice Aspiration Cytologic Examination (SPACE), could be recommended for a detailed examination to diagnose pancreatic carcinoma earlier.
Open AccessEarly Diagnosis to Improve the Poor Prognosis of Pancreatic Cancer
Pancreatic cancer (PC) has a poor prognosis due to delayed diagnosis. Early diagnosis is the most important factor for improving prognosis. For early diagnosis of PC, patients with clinical manifestations suggestive of PC and high risk for developing PC need to be selected for examinations for PC. Signs suggestive of PC (e.g., symptoms, diabetes mellitus, acute pancreatitis, or abnormal results of blood examinations) should not be missed, and the details of risks for PC (e.g., familial history of PC, intraductal mucin producing neoplasm, chronic pancreatitis, hereditary pancreatitis, or life habit) should be understood. Multidetector computed tomography (MDCT) and magnetic resonance imaging (MRI) can be performed for diagnosing PC, but the diagnostic ability of these examinations for PC is limited. Endoscopic diagnostic procedures, such as endoscopic ultrasonography, including fine-needle aspiration, and endoscopic retrograde pancreatocholangiography, including Serial Pancreatic-juice Aspiration Cytologic Examination (SPACE), could be recommended for a detailed examination to diagnose pancreatic carcinoma earlier.
- Open Access
- 29 July 2016
- Published by Springer Nature in BMC Gastroenterology
- Vol. 16 (1) , 83
Associations between polymorphisms in folate-metabolizing genes and pancreatic cancer risk in Japanese subjects
Evidence supporting the associations between folate metabolizing gene polymorphisms and pancreatic cancer has been inconclusive. We examined their associations in a case-control study of Japanese subjects. Our case-control study involved 360 newly diagnosed pancreatic cancer cases and 400 frequency-matched, non-cancer control subjects. We genotyped four folate metabolizing gene polymorphisms, including two polymorphisms (rs1801133 and rs1801131) in the methylenetetrahydrofolate (MTHFR) gene, one polymorphism (rs1801394) in the 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR) gene and one polymorphism (rs1805087) in the 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR) gene. Genotyping was performed using Fluidigm SNPtype assays. Unconditional logistic regression methods were used to estimate odds ratios (ORs) and 95 % confidence intervals (CIs) for the associations between folate metabolizing gene variants and pancreatic cancer risk. Overall we did not observe a significant association between these four genotypes and pancreatic cancer risk. For rs1801133, compared with individuals with the CC genotype of MTHFR C677T, the OR for those with the CT genotype and TT genotype was 0.87 (0.62-1.22) and 0.99 (0.65-1.51), respectively. For rs1801131, individuals with the CC genotype had approximately 1.2-fold increased risk compared with those with the AA genotype, but the association was not statistically significant. In analyses stratified by smoking and drinking status, no significant associations were noted for C677T genotypes. No significant interactions were observed with smoking and drinking with respect to pancreatic cancer risk. Our data did not support the hypothesis that MTHFR polymorphisms or other polymorphisms in the folate metabolizing pathway are associated with pancreatic cancer risk.
- 29 July 2016
- Published by Springer Nature in BMC Gastroenterology
- Vol. 16 (1) , 83
Open AccessAssociations between polymorphisms in folate-metabolizing genes and pancreatic cancer risk in Japanese subjects
Evidence supporting the associations between folate metabolizing gene polymorphisms and pancreatic cancer has been inconclusive. We examined their associations in a case-control study of Japanese subjects. Our case-control study involved 360 newly diagnosed pancreatic cancer cases and 400 frequency-matched, non-cancer control subjects. We genotyped four folate metabolizing gene polymorphisms, including two polymorphisms (rs1801133 and rs1801131) in the methylenetetrahydrofolate (MTHFR) gene, one polymorphism (rs1801394) in the 5-methyltetrahydrofolate-homocysteine methyltransferase reductase (MTRR) gene and one polymorphism (rs1805087) in the 5-methyltetrahydrofolate-homocysteine methyltransferase (MTR) gene. Genotyping was performed using Fluidigm SNPtype assays. Unconditional logistic regression methods were used to estimate odds ratios (ORs) and 95 % confidence intervals (CIs) for the associations between folate metabolizing gene variants and pancreatic cancer risk. Overall we did not observe a significant association between these four genotypes and pancreatic cancer risk. For rs1801133, compared with individuals with the CC genotype of MTHFR C677T, the OR for those with the CT genotype and TT genotype was 0.87 (0.62-1.22) and 0.99 (0.65-1.51), respectively. For rs1801131, individuals with the CC genotype had approximately 1.2-fold increased risk compared with those with the AA genotype, but the association was not statistically significant. In analyses stratified by smoking and drinking status, no significant associations were noted for C677T genotypes. No significant interactions were observed with smoking and drinking with respect to pancreatic cancer risk. Our data did not support the hypothesis that MTHFR polymorphisms or other polymorphisms in the folate metabolizing pathway are associated with pancreatic cancer risk.
- 28 July 2016
- Published by Georg Thieme Verlag KG in Seminars in Liver Disease
- Vol. 36 (03) , 291-296
The Treatment of IgG4-Related Diseases in the Hepatobiliary-Pancreatic System
An accurate diagnosis should be made before treatment of autoimmune pancreatitis and immunoglobulin G4-related sclerosing cholangitis. Once a diagnosis has been established, steroids are the standard therapy and symptoms are the major indications. Before steroid therapy, obstructive jaundice and hyperglycemia should be controlled. An initial dose of 0.6 mg/kg/d of oral prednisolone is administered for 2 to 4 weeks, and is gradually tapered over 2 to 3 months. After steroid therapy has begun, blood and imaging tests are performed periodically. Patients with a poor response to steroids should be reevaluated on suspicion of malignancy. To prevent relapse, maintenance therapy using low-dose prednisolone (2.5–5 mg/d) for 1 to 3 years is recommended in Japan. Proximal biliary stricture is reported to be a predictor of relapse. Readministration and dose-up of steroids are effective for relapses. In Western countries, immunosuppressive drugs and rituximab have also been shown to be effective. The optimal treatment regimen should be addressed in future randomized, controlled clinical trials.
- 28 July 2016
- Published by Georg Thieme Verlag KG in Seminars in Liver Disease
- Vol. 36 (03) , 291-296
The Treatment of IgG4-Related Diseases in the Hepatobiliary-Pancreatic System
An accurate diagnosis should be made before treatment of autoimmune pancreatitis and immunoglobulin G4-related sclerosing cholangitis. Once a diagnosis has been established, steroids are the standard therapy and symptoms are the major indications. Before steroid therapy, obstructive jaundice and hyperglycemia should be controlled. An initial dose of 0.6 mg/kg/d of oral prednisolone is administered for 2 to 4 weeks, and is gradually tapered over 2 to 3 months. After steroid therapy has begun, blood and imaging tests are performed periodically. Patients with a poor response to steroids should be reevaluated on suspicion of malignancy. To prevent relapse, maintenance therapy using low-dose prednisolone (2.5–5 mg/d) for 1 to 3 years is recommended in Japan. Proximal biliary stricture is reported to be a predictor of relapse. Readministration and dose-up of steroids are effective for relapses. In Western countries, immunosuppressive drugs and rituximab have also been shown to be effective. The optimal treatment regimen should be addressed in future randomized, controlled clinical trials.
- 1 January 2016
- Published by Japan Gastrointestinal Endoscopy Society in Progress of Digestive Endoscopy
- Vol. 88 (1) , 104-105
A case of Gastric Inflammatory Fibroid polyp incarcerated into the duodenum caused anemia
An 80-years-old woman was admitted to our hospital complaining of feeling uncomfortable bowel distention after eating. Endoscopic examination showed a protruding lesion completely prolapsing into the duodenal bulb. After we corrected the incarcerated tumor by 2 channel-double-grasper method, endoscopic examination and upper gastrointestinal series revealed the polyp-like formation which the appearance of the overlying mucosa is smooth and the top is decidualized. Pathological examination of biopsy specimen showed no evidence of malignancy. The tumor was guessed as an inflammatory fibroid polyp (IFP) arising from the anterior wall of pyloric zone. To diagnose the tumor, a distal partial gastrectomy was performed. Pathologically, the 4-cm-diameter tumor was an IFP. We report a suggestive case of IFP of the gastric antrum prolapsing into duodenum.
- 1 January 2016
- Published by Japan Gastrointestinal Endoscopy Society in Progress of Digestive Endoscopy
- Vol. 88 (1) , 104-105
A case of Gastric Inflammatory Fibroid polyp incarcerated into the duodenum caused anemia
An 80-years-old woman was admitted to our hospital complaining of feeling uncomfortable bowel distention after eating. Endoscopic examination showed a protruding lesion completely prolapsing into the duodenal bulb. After we corrected the incarcerated tumor by 2 channel-double-grasper method, endoscopic examination and upper gastrointestinal series revealed the polyp-like formation which the appearance of the overlying mucosa is smooth and the top is decidualized. Pathological examination of biopsy specimen showed no evidence of malignancy. The tumor was guessed as an inflammatory fibroid polyp (IFP) arising from the anterior wall of pyloric zone. To diagnose the tumor, a distal partial gastrectomy was performed. Pathologically, the 4-cm-diameter tumor was an IFP. We report a suggestive case of IFP of the gastric antrum prolapsing into duodenum.
- 1 January 2015
- Published by Japan Gastrointestinal Endoscopy Society in Progress of Digestive Endoscopy
- Vol. 86 (1) , 204-205
A case of rapid growing rectal cancer for the duration of taking Calcium Polystyrene Sulfonate
- 1 January 2015
- Published by Japan Gastrointestinal Endoscopy Society in Progress of Digestive Endoscopy
- Vol. 86 (1) , 204-205
A case of rapid growing rectal cancer for the duration of taking Calcium Polystyrene Sulfonate